AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 30th, there was short interest totaling 79,118 shares, a growth of 312.9% from the April 15th total of 19,163 shares. Currently, 4.8% of the shares of the company are short sold. Based on an average daily volume of 104,102 shares, the short-interest ratio is presently 0.8 days.
AdvisorShares Psychedelics ETF Stock Performance
NYSEARCA PSIL traded down $0.40 during trading on Friday, reaching $19.97. The company’s stock had a trading volume of 24,437 shares, compared to its average volume of 28,660. AdvisorShares Psychedelics ETF has a 12 month low of $11.97 and a 12 month high of $22.49. The firm has a 50 day moving average price of $18.19 and a 200 day moving average price of $17.95.
Institutional Trading of AdvisorShares Psychedelics ETF
An institutional investor recently bought a new position in AdvisorShares Psychedelics ETF stock. CIBC Bancorp USA Inc. purchased a new position in shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL – Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 25,019 shares of the company’s stock, valued at approximately $475,000. CIBC Bancorp USA Inc. owned 2.50% of AdvisorShares Psychedelics ETF at the end of the most recent quarter.
About AdvisorShares Psychedelics ETF
The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.
Recommended Stories
- Five stocks we like better than AdvisorShares Psychedelics ETF
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for AdvisorShares Psychedelics ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvisorShares Psychedelics ETF and related companies with MarketBeat.com's FREE daily email newsletter.
